Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

[18F]Fluciclovine PET discrimination between high- and low-grade gliomas.

Parent EE, Benayoun M, Ibeanu I, Olson JJ, Hadjipanayis CG, Brat DJ, Adhikarla V, Nye J, Schuster DM, Goodman MM.

EJNMMI Res. 2018 Jul 25;8(1):67. doi: 10.1186/s13550-018-0415-3.

2.

In Reply: Incidence and Predictive Factors of Sepsis Following Adult Spinal Deformity Surgery.

Zuckerman SL, Lakomkin N, Hadjipanayis CG, Shaffrey CI, Smith JS, Cheng JS.

Neurosurgery. 2018 Jul 1;83(1):E44-E45. doi: 10.1093/neuros/nyy117. No abstract available.

PMID:
29660050
3.

Convection-enhanced delivery of cetuximab conjugated iron-oxide nanoparticles for treatment of spontaneous canine intracranial gliomas.

Freeman AC, Platt SR, Holmes S, Kent M, Robinson K, Howerth E, Eagleson J, Bouras A, Kaluzova M, Hadjipanayis CG.

J Neurooncol. 2018 May;137(3):653-663. doi: 10.1007/s11060-018-2764-1. Epub 2018 Jan 19.

PMID:
29350351
4.

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Emerging Therapies for the Treatment of Patients With Vestibular Schwannomas.

Van Gompel JJ, Agazzi S, Carlson ML, Adewumi DA, Hadjipanayis CG, Uhm JH, Olson JJ.

Neurosurgery. 2018 Feb 1;82(2):E52-E54. doi: 10.1093/neuros/nyx516.

PMID:
29309638
5.

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Radiosurgery and Radiation Therapy in the Management of Patients With Vestibular Schwannomas.

Germano IM, Sheehan J, Parish J, Atkins T, Asher A, Hadjipanayis CG, Burri SH, Green S, Olson JJ.

Neurosurgery. 2018 Feb 1;82(2):E49-E51. doi: 10.1093/neuros/nyx515.

PMID:
29309637
6.

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Surgical Resection for the Treatment of Patients With Vestibular Schwannomas.

Hadjipanayis CG, Carlson ML, Link MJ, Rayan TA, Parish J, Atkins T, Asher AL, Dunn IF, Corrales CE, Van Gompel JJ, Sughrue M, Olson JJ.

Neurosurgery. 2018 Feb 1;82(2):E40-E43. doi: 10.1093/neuros/nyx512.

PMID:
29309632
7.

Incidence and Predictive Factors of Sepsis Following Adult Spinal Deformity Surgery.

Zuckerman SL, Lakomkin N, Stannard BP, Hadjipanayis CG, Shaffrey CI, Smith JS, Cheng JS.

Neurosurgery. 2017 Dec 21. doi: 10.1093/neuros/nyx578. [Epub ahead of print]

PMID:
29281103
8.

Non-routine discharge disposition is associated with post-discharge complications and 30-day readmissions following craniotomy for brain tumor resection.

Lakomkin N, Hadjipanayis CG.

J Neurooncol. 2018 Feb;136(3):595-604. doi: 10.1007/s11060-017-2689-0. Epub 2017 Dec 5.

PMID:
29209875
9.

5-Aminolevulinic Acid Guided Sampling of Glioblastoma Microenvironments Identifies Pro-Survival Signaling at Infiltrative Margins.

Ross JL, Cooper LAD, Kong J, Gutman D, Williams M, Tucker-Burden C, McCrary MR, Bouras A, Kaluzova M, Dunn WD Jr, Duong D, Hadjipanayis CG, Brat DJ.

Sci Rep. 2017 Nov 15;7(1):15593. doi: 10.1038/s41598-017-15849-w.

10.

Hospital-acquired conditions: predictors and implications for outcomes following spine tumor resection.

Lakomkin N, Hadjipanayis CG.

J Neurosurg Spine. 2017 Dec;27(6):717-722. doi: 10.3171/2017.5.SPINE17439. Epub 2017 Oct 13.

PMID:
29027893
11.

Resident participation is not associated with postoperative adverse events, reoperation, or prolonged length of stay following craniotomy for brain tumor resection.

Lakomkin N, Hadjipanayis CG.

J Neurooncol. 2017 Dec;135(3):613-619. doi: 10.1007/s11060-017-2614-6. Epub 2017 Aug 30.

PMID:
28856528
12.

Meningioma With Tyrosine-Rich Crystalloids: A Case Report and Review of the Literature.

Reinertsen E, Neill SG, Nael K, Brat DJ, Hadjipanayis CG.

Int J Surg Pathol. 2018 Apr;26(2):157-160. doi: 10.1177/1066896917727100. Epub 2017 Aug 17.

13.

Occam's Razor Could Not Cut It: Tale of 2 Headaches in a Postpartum Patient: A Case Report.

Dolak JA, Hadjipanayis CG, Demma LJ.

A A Case Rep. 2017 Oct 15;9(8):233-235. doi: 10.1213/XAA.0000000000000580.

PMID:
28691978
14.

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CECĀ·3): a multicentre, randomised, controlled, phase 3 trial.

Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D.

Lancet Oncol. 2017 Aug;18(8):1049-1060. doi: 10.1016/S1470-2045(17)30441-2. Epub 2017 Jul 4.

15.

Stereotactic Laser Interstitial Thermal Therapy for Recurrent High-Grade Gliomas.

Lee I, Kalkanis S, Hadjipanayis CG.

Neurosurgery. 2016 Dec;79 Suppl 1:S24-S34. Review.

PMID:
27861323
16.

Factors impacting cerebrospinal fluid leak rates in endoscopic sellar surgery.

Karnezis TT, Baker AB, Soler ZM, Wise SK, Rereddy SK, Patel ZM, Oyesiku NM, DelGaudio JM, Hadjipanayis CG, Woodworth BA, Riley KO, Lee J, Cusimano MD, Govindaraj S, Psaltis A, Wormald PJ, Santoreneos S, Sindwani R, Trosman S, Stokken JK, Woodard TD, Recinos PF, Vandergrift WA 3rd, Schlosser RJ.

Int Forum Allergy Rhinol. 2016 Nov;6(11):1117-1125. doi: 10.1002/alr.21783. Epub 2016 Aug 23.

PMID:
27552303
17.

Successful repair of intraoperative cerebrospinal fluid leaks improves outcomes in endoscopic skull base surgery.

Shahangian A, Soler ZM, Baker A, Wise SK, Rereddy SK, Patel ZM, Oyesiku NM, DelGaudio JM, Hadjipanayis CG, Woodworth BA, Riley KO, Lee J, Cusimano MD, Govindaraj S, Khan MN, Psaltis A, Wormald PJ, Santoreneos S, Sindwani R, Trosman S, Stokken JK, Woodard TD, Recinos PF, Vandergrift WA 3rd, Boling C, Schlosser RJ.

Int Forum Allergy Rhinol. 2017 Jan;7(1):80-86. doi: 10.1002/alr.21845. Epub 2016 Aug 31.

PMID:
27579523
18.

A systematic pipeline for the objective comparison of whole-brain spectroscopic MRI with histology in biopsy specimens from grade III glioma.

Cordova JS, Gurbani SS, Olson JJ, Liang Z, Cooper LA, Shu HG, Schreibmann E, Neill SG, Hadjipanayis CG, Holder CA, Shim H.

Tomography. 2016 Jun;2(2):106-116.

19.

Prophylactic antiepileptic drug administration following brain tumor resection: results of a recent AANS/CNS Section on Tumors survey.

Dewan MC, Thompson RC, Kalkanis SN, Barker FG 2nd, Hadjipanayis CG.

J Neurosurg. 2017 Jun;126(6):1772-1778. doi: 10.3171/2016.4.JNS16245. Epub 2016 Jun 24.

PMID:
27341048
20.

Spinal cord ependymoma: a review of the literature and case series of ten patients.

Celano E, Salehani A, Malcolm JG, Reinertsen E, Hadjipanayis CG.

J Neurooncol. 2016 Jul;128(3):377-86. doi: 10.1007/s11060-016-2135-8. Epub 2016 May 6. Review.

21.

Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients.

Cordova JS, Shu HK, Liang Z, Gurbani SS, Cooper LA, Holder CA, Olson JJ, Kairdolf B, Schreibmann E, Neill SG, Hadjipanayis CG, Shim H.

Neuro Oncol. 2016 Aug;18(8):1180-9. doi: 10.1093/neuonc/now036. Epub 2016 Mar 15.

22.

Intraoperative Spectroscopy with Ultrahigh Sensitivity for Image-Guided Surgery of Malignant Brain Tumors.

Kairdolf BA, Bouras A, Kaluzova M, Sharma AK, Wang MD, Hadjipanayis CG, Nie S.

Anal Chem. 2016 Jan 5;88(1):858-67. doi: 10.1021/acs.analchem.5b03453. Epub 2015 Dec 7.

PMID:
26587976
23.

Adult Intramedullary Teratoma of the Spinal Cord: A Case Report and Review of Literature.

Turan N, Halani SH, Baum GR, Neill SG, Hadjipanayis CG.

World Neurosurg. 2016 Mar;87:661.e23-30. doi: 10.1016/j.wneu.2015.10.053. Epub 2015 Nov 4.

PMID:
26546992
24.

Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery.

Cordova JS, Gurbani SS, Holder CA, Olson JJ, Schreibmann E, Shi R, Guo Y, Shu HK, Shim H, Hadjipanayis CG.

Mol Imaging Biol. 2016 Jun;18(3):454-62. doi: 10.1007/s11307-015-0900-2.

25.

What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?

Hadjipanayis CG, Widhalm G, Stummer W.

Neurosurgery. 2015 Nov;77(5):663-73. doi: 10.1227/NEU.0000000000000929. Review.

26.

Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification.

Vigneswaran K, Neill S, Hadjipanayis CG.

Ann Transl Med. 2015 May;3(7):95. doi: 10.3978/j.issn.2305-5839.2015.03.57. Review.

27.

Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles.

Bouras A, Kaluzova M, Hadjipanayis CG.

J Neurooncol. 2015 Aug;124(1):13-22. doi: 10.1007/s11060-015-1807-0. Epub 2015 May 17.

28.

Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles.

Kaluzova M, Bouras A, Machaidze R, Hadjipanayis CG.

Oncotarget. 2015 Apr 20;6(11):8788-806.

29.

The application of magnetic nanoparticles for the treatment of brain tumors.

Mahmoudi K, Hadjipanayis CG.

Front Chem. 2014 Dec 3;2:109. doi: 10.3389/fchem.2014.00109. eCollection 2014. No abstract available.

30.

Human Brat ortholog TRIM3 is a tumor suppressor that regulates asymmetric cell division in glioblastoma.

Chen G, Kong J, Tucker-Burden C, Anand M, Rong Y, Rahman F, Moreno CS, Van Meir EG, Hadjipanayis CG, Brat DJ.

Cancer Res. 2014 Aug 15;74(16):4536-48. doi: 10.1158/0008-5472.CAN-13-3703. Epub 2014 Jun 19.

31.

Quantitative tumor segmentation for evaluation of extent of glioblastoma resection to facilitate multisite clinical trials.

Cordova JS, Schreibmann E, Hadjipanayis CG, Guo Y, Shu HK, Shim H, Holder CA.

Transl Oncol. 2014 Feb 1;7(1):40-7. eCollection 2014 Feb.

32.

The history of neurosurgery and its relation to the development and refinement of the frontotemporal craniotomy.

Ormond DR, Hadjipanayis CG.

Neurosurg Focus. 2014 Apr;36(4):E12. doi: 10.3171/2014.2.FOCUS13548. Review.

PMID:
24684325
33.

Evolving applications of fluorescence technology in neurosurgery.

Cohen-Gadol AA, Roberts DW, Hadjipanayis CG.

Neurosurg Focus. 2014 Feb;36(2):Introduction. doi: 10.3171/2013.12.FOCUS13582. No abstract available.

PMID:
24484263
34.

Neuroendoscopic colloid cyst resection: a case cohort with follow-up and patient satisfaction.

Sribnick EA, Dadashev VY, Miller BA, Hawkins S, Hadjipanayis CG.

World Neurosurg. 2014 Mar-Apr;81(3-4):584-93. doi: 10.1016/j.wneu.2013.12.006. Epub 2013 Dec 22.

PMID:
24368424
35.

The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin.

Wang Q, Wei F, Lv G, Li C, Liu T, Hadjipanayis CG, Zhang G, Hao C, Bellail AC.

BMC Cancer. 2013 Nov 4;13:521. doi: 10.1186/1471-2407-13-521.

36.

The Supraorbital Keyhole Craniotomy through an Eyebrow Incision: Its Origins and Evolution.

Ormond DR, Hadjipanayis CG.

Minim Invasive Surg. 2013;2013:296469. doi: 10.1155/2013/296469. Epub 2013 Jul 10.

37.

Neuroendoscopic Resection of Intraventricular Tumors and Cysts through a Working Channel with a Variable Aspiration Tissue Resector: A Feasibility and Safety Study.

Nduom EK, Sribnick EA, Ormond DR, Hadjipanayis CG.

Minim Invasive Surg. 2013;2013:471805. doi: 10.1155/2013/471805. Epub 2013 Jun 13.

38.

Incidental sinonasal findings identified during preoperative evaluation for endoscopic transsphenoidal approaches.

Laury AM, Oyesiku NM, Hadjipanayis CG, Delgaudio JM, Wise SK.

Am J Rhinol Allergy. 2013 May-Jun;27(3):202-5. doi: 10.2500/ajra.2013.27.3871.

39.

Canine model of convection-enhanced delivery of cetuximab-conjugated iron-oxide nanoparticles monitored with magnetic resonance imaging.

Platt S, Nduom E, Kent M, Freeman C, Machaidze R, Kaluzova M, Wang L, Mao H, Hadjipanayis CG.

Clin Neurosurg. 2012;59:107-13. No abstract available.

40.

Nanotechnology applications for glioblastoma.

Nduom EK, Bouras A, Kaluzova M, Hadjipanayis CG.

Neurosurg Clin N Am. 2012 Jul;23(3):439-49. doi: 10.1016/j.nec.2012.04.006. Epub 2012 Jun 14. Review.

41.

Lectins identify glycan biomarkers on glioblastoma-derived cancer stem cells.

Tucker-Burden C, Chappa P, Krishnamoorthy M, Gerwe BA, Scharer CD, Heimburg-Molinaro J, Harris W, Usta SN, Eilertson CD, Hadjipanayis CG, Stice SL, Brat DJ, Nash RJ.

Stem Cells Dev. 2012 Sep 1;21(13):2374-86. doi: 10.1089/scd.2011.0369. Epub 2012 Apr 27.

42.

Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy.

Wankhede M, Bouras A, Kaluzova M, Hadjipanayis CG.

Expert Rev Clin Pharmacol. 2012 Mar;5(2):173-86. doi: 10.1586/ecp.12.1. Review.

43.

Stereotactic body radiosurgery for spinal metastatic disease: an evidence-based review.

Hall WA, Stapleford LJ, Hadjipanayis CG, Curran WJ, Crocker I, Shu HK.

Int J Surg Oncol. 2011;2011:979214. doi: 10.1155/2011/979214. Epub 2011 Jul 10.

44.

Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment.

Nduom EK, Hadjipanayis CG, Van Meir EG.

Cancer J. 2012 Jan-Feb;18(1):100-6. doi: 10.1097/PPO.0b013e3182452e0d. Review.

45.

A national fundamentals curriculum for neurosurgery PGY1 residents: the 2010 Society of Neurological Surgeons boot camp courses.

Selden NR, Origitano TC, Burchiel KJ, Getch CC, Anderson VC, McCartney S, Abdulrauf SI, Barrow DL, Ehni BL, Grady MS, Hadjipanayis CG, Heilman CB, Popp AJ, Sawaya R, Schuster JM, Wu JK, Barbaro NM.

Neurosurgery. 2012 Apr;70(4):971-81; discussion 981. doi: 10.1227/NEU.0b013e31823d7a45.

PMID:
22015813
46.

Current and future clinical applications for optical imaging of cancer: from intraoperative surgical guidance to cancer screening.

Hadjipanayis CG, Jiang H, Roberts DW, Yang L.

Semin Oncol. 2011 Feb;38(1):109-18. doi: 10.1053/j.seminoncol.2010.11.008.

47.

Open biopsy in patients with acute progressive neurologic decline and absence of mass lesion.

Schuette AJ, Taub JS, Hadjipanayis CG, Olson JJ.

Neurology. 2010 Aug 3;75(5):419-24. doi: 10.1212/WNL.0b013e3181eb5889.

48.

EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.

Hadjipanayis CG, Machaidze R, Kaluzova M, Wang L, Schuette AJ, Chen H, Wu X, Mao H.

Cancer Res. 2010 Aug 1;70(15):6303-12. doi: 10.1158/0008-5472.CAN-10-1022. Epub 2010 Jul 20.

49.

Immobilization of magnetic iron oxide nanoparticles on laponite discs - an easy way to biocompatible ferrofluids and ferrogels.

Tzitzios V, Basina G, Bakandritsos A, Hadjipanayis CG, Mao H, Niarchos D, Hadjipanayis GC, Tucek J, Zboril R.

J Mater Chem. 2010 Jan 1;20(26):5418-5428.

50.

Full scope of options.

Hadjipanayis CG, Schuette AJ, Boulis N, Hao C, Barrow DL, Teo C.

Neurosurgery. 2010 Jul;67(1):197-203; discussion 203-4. doi: 10.1227/01.NEU.0000370602.15820.E4.

Supplemental Content

Loading ...
Support Center